Gustavo Dziewczapolski, Scientific DirectorSep 302 min readOne Step Closer to LAMA2-RD Clinical Trials: Modalis TherapeuticsModalis Therapeutics program for LAMA2-RD gene therapy granted Rare Pediatric Disease Designation by FDA.
